Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,890.88 +1,599.36 (+2.45%) CMC Crypto 200
1,350.62 -23.22 (-1.69%)
TriSalus Life Sciences, Inc. (TLSI)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 291.95M |
| Enterprise value | 281.77M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.92 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 15.22 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.67 |
| 52-week change 3 | -6.01% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 12.83 |
| 52-week low 3 | 3.32 |
| 50-day moving average 3 | 9.66 |
| 200-day moving average 3 | 7.63 |
Share statistics
| Avg vol (3-month) 3 | 41.09k |
| Avg vol (10-day) 3 | 18.19k |
| Shares outstanding 5 | 30.1M |
| Implied shares outstanding 6 | 30.1M |
| Float 8 | 16.76M |
| % held by insiders 1 | 54.40% |
| % held by institutions 1 | 12.87% |
| Shares short (30 Apr 2024) 4 | 169.64k |
| Short ratio (30 Apr 2024) 4 | 3.28 |
| Short % of float (30 Apr 2024) 4 | 1.05% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.56% |
| Shares short (prior month 28 Mar 2024) 4 | 287.41k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -322.41% |
Management effectiveness
| Return on assets (ttm) | -141.84% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 18.51M |
| Revenue per share (ttm) | 1.97 |
| Quarterly revenue growth (yoy) | 77.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -53.45M |
| Net income avi to common (ttm) | -63.28M |
| Diluted EPS (ttm) | -6.73 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 11.78M |
| Total cash per share (mrq) | 0.44 |
| Total debt (mrq) | 1.59M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.42 |
| Book value per share (mrq) | -0.98 |
Cash flow statement
| Operating cash flow (ttm) | -50.05M |
| Levered free cash flow (ttm) | -51.81M |
© 2024 Yahoo. All rights reserved.